NLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population

Tissue Antigens

Volumn 53, Issue 3, 1999, Pages 269-274

  Hirayama, Kenji ^a   Chen, H ^b   Kikuchi, M ^a   Yin, T ^b   Gu, X ^b   Liu, J ^c   Zhang, S ^b   Yuan, H ^c  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Jiangxi Provincial Institute of Parasitic Diseases   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

HLA DP; HLA DR; Liver fibrosis; Schistosomiasis; Ultrasonography

Indexed keywords

HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CHINESE; DISEASE SEVERITY; FEMALE; HAPLOTYPE; HLA SYSTEM; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; ALLELE; CHINA; ECHOGRAPHY; GENETIC PREDISPOSITION; GENETICS; LIVER; LIVER CIRRHOSIS;

SCHISTOSOMA JAPONICUM;

ALLELES; CHINA; GENETIC PREDISPOSITION TO DISEASE; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LIVER; LIVER CIRRHOSIS; SCHISTOSOMIASIS JAPONICA;

EID: 0033088991     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530307.x     Document Type: Article

References (24)

1. Cheerer AW. Schistosomiasis Infection versus disease and hypersensitivity versus immunity. Am J Pathol 1993: 142: 699-702.
2. Wynn TA, Cheerer AW, Jankovic D et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995: 17: 594-6.
3. Kaplan MH, Whitfield JR, Boros DL, Grusby MJ. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 1998: 15: 160: 1850-6.
4. Wiest PM, Wu G, Zhang S et al. Schistsomiasis japonica on Jishan island, Jiangxi province, People's Republic of China: persistence of hepatic fibrosis after reduction of the prevalence of infection with age. Trans Royal Soc Trop Med Hyg 1992: 87: 290-4.
5. Salam EA, Ishaac S, Mahmoud AA. Histocompatibilty-linked susceptibility for hepatospleenomegaly in human schistosomiasis mansoni. J Immunol 1979: 123: 1829-31.
6. Ohta N, Hayashi M, Tormis LC, Blas BL, Nosenas JS, Sasazuki T. Immunogenetic factors involved in the pathogenesis of distinct clinical manifestations of schistosomiasis japonica in the Philippine population. Trans Royal Soc Trop Med Hyg 1987: 81: 292-6.
7. Ohta N, Nishimura Y, Iuchi M, Sasazuki T. Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man. Clin Exp Immunol 1982: 49: 493-9.
8. The Cairo Working Group. The use of diagnostic ultrasound in Schistosomiasis: Attempts at standardization of methodolog. Acta Tropica 1992: 51: 45-63.
9. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasuki T, eds. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol 1. Oxford: Oxford University Press, 1991: 397-419.
10. Hirayama K, Chen H, Kikuchi M et al. Glycine-Valine dimorphism at the 86th amino acid of HLA-DRB1 influenced the prognosis of post - schistosomal hepatic fibrosis. J Infect Dis 1998: 177: 1682-6.
11. Hatz C, Murakami H, Jenkins JM. A review of the literature on the use of ultrasonography in Schistosomiasis with special reference to its use in field studies. 3. Schistosoma japonicum. Acta Tropica 1992: 51: 29-36.
12. Yoshida M, Kimura A, Numano F, Sasazuki T. Polymerase-Chain-Reaction-based analysis of polymorphism in the HLA-B gene. Hum Immunol 1992: 34: 257-66.
13. Hirayama K, Mohd Zaidi AS, Lokman HS et al. Molecular analysis of HLA-B in the Malaysian aborigines. Tissue Antigens 1996: 48: 692-7.
14. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955: 19: 251-3.
15. Mittal KK. The HLA polymorphism and susceptibility to disease, Vox Sang 1976: 31: 161.
16. Li Y, Yu DB, Li YS, Ross AG, McManus DP. Infections with hepatitis B virus in three villages endemic for Schistosomiasis japonica in the Dongting Lake region of China. Ann Trop Med Parasitol 1997: 91: 323-7.
17. Yuan HC. Epidemiotogical features and control of schistosomiasis japonica in China. Mem Inst Oswaldo Cruz 1992: 87: 241.
18. Lin D, Zhang S, Murakami H et al. Impact mass chemotherapy with praziquantel on schistosomiasis control in Fanhu village, People's Republic of China. Southeast Asian J Trop Med Public Health 1997: 28: 274-9.
19. Secor WE, Corral H, dos del Reis MG et al. Association of Hepatosplenic Schistosomiasis with HLA-DQBI*0201. J Infect Dis 1996: 174: 1131-5.
20. Dayer JM. Regulation of IL-1/TNF, their Natural Inhibitors, and Other Cytokines in Chronic inflammation. The Immunologist 1997: 5: 192-6.
21. Hirayama K, Mastushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigens in humans. Nature 1987: 327: 426-30.
22. Falk K, Rotzschke O, Stefan S, Gunther J, Rammensee HG. Pool sequencing of natural HLA-DR,DQ, and DP ligands reveals detailed peptide motif, constraints of processing, and general rules. Immunogenetics 1994: 39: 230-42.
23. Bergquist NR, Colley DG. Schistosomiasis Vaccines: Research to Development. Parasitology Today 1998: 14: 99-104.
24. Kalinna BH, McManus DP. A vaccine against the Asian Schistosoma japonicum: an update on paramyosin as a target of protective Immunity. Int J Parasitology 1997: 27: 1213-19.